BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10211850)

  • 1. The hormonal response to a d-fenfluramine challenge in trained and sedentary men.
    Strachan AT; Maughan RJ
    Med Sci Sports Exerc; 1999 Apr; 31(4):547-53. PubMed ID: 10211850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN
    Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
    Cleare AJ; Bond AJ
    Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol and serotonin indices in depressed and suicidal patients.
    Sarchiapone M; Camardese G; Roy A; Della Casa S; Satta MA; Gonzalez B; Berman J; De Risio S
    J Affect Disord; 2001 Feb; 62(3):217-9. PubMed ID: 11223109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.
    Levy AD; Li Q; Van de Kar LD
    Neuropharmacology; 1994; 33(3-4):335-42. PubMed ID: 7984271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB; Smythe GA
    Psychiatry Res; 1991 Nov; 39(2):141-53. PubMed ID: 1686811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.
    Soloff PH; Lynch KG; Moss HB
    Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cholesterol and serotonergic function in major depressive disorder.
    Papakostas GI; Petersen T; Mischoulon D; Hughes ME; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    Psychiatry Res; 2003 May; 118(2):137-45. PubMed ID: 12798978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
    Palazidou E; Stephenson J; Butler J; Coskeran P; Chambers S; McGregor AM
    Psychopharmacology (Berl); 1995 Jun; 119(3):311-4. PubMed ID: 7675967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
    Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.